Showing results (1251-1260 of 1,332) with videos related to

Sort By:
Pageof 134
JCI Insight|May 19, 2026
Hepatocyte hedgehog signaling controls ferroptosis to alleviate aging-related organ dysfunctionJi Hye Jun, Rajesh K Dutta, Soon-Woo Cho, et al.
Case Reports in Gastroenterology|September 27, 2012
Colonic mucosa-associated lymphoid tissue lymphomaRisaburo Akasaka, Toshimi Chiba, Amit K Dutta, et al.
Mutation Research|April 12, 2002
Enhanced frequency of micronuclei in individuals exposed to arsenic through drinking water in West Bengal, IndiaA Basu, J Mahata, A K Roy, et al.
Cell Death and Differentiation|October 24, 2015
DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53S K Alam, V K Yadav, S Bajaj, et al.
The Indian Journal of Medical Research|May 8, 2012
Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical CentersAnand Manoharan, Madhan Sugumar, Anil Kumar, et al.
The Journal of Antimicrobial Chemotherapy|September 7, 2004
Genetic relatedness of ciprofloxacin-resistant Shigella dysenteriae type 1 strains isolated in south AsiaKaisar A Talukder, Bijay K Khajanchi, M Aminul Islam, et al.
APL Bioengineering|February 16, 2026
Cell shape and maturation impacts α-actinin-2 tension in iPSC-derived cardiomyocytesPalash K Dutta, Joshua M Toth, Subramanian Sundaram, et al.
International Journal of Nanomedicine|May 10, 2023
Mitigation of SARS-CoV-2 by Using Transition Metal Nanozeolites and Quaternary Ammonium Compounds as Antiviral Agents in Suspensions and Soft Fabric MaterialsIsrael Guerrero-Arguero, Siddiqur Rahman Khan, Brandon M Henry, et al.
Nanomedicine (London, England)|March 26, 2021
Enriched pharmacokinetic behavior and antitumor efficacy of thymoquinone by liposomal deliveryHari Krishnareddy Rachamalla, Santanu Bhattacharya, Ajaz Ahmad, et al.
Hepatology (Baltimore, Md.)|April 10, 2023
Targeting senescent hepatocytes using the thrombomodulin-PAR1 inhibitor vorapaxar ameliorates NAFLD progressionRaquel Maeso-Díaz, Kuo Du, Christopher Pan, et al.
Pageof 134